These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27346312)

  • 21. [Treatment of osteoporosis in hypogonadal men].
    Marumo K; Hata K; Hagiuda J
    Clin Calcium; 2016 Jul; 26(7):1053-9. PubMed ID: 27346318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism.
    Bojesen A; Kristensen K; Birkebaek NH; Fedder J; Mosekilde L; Bennett P; Laurberg P; Frystyk J; Flyvbjerg A; Christiansen JS; Gravholt CH
    Diabetes Care; 2006 Jul; 29(7):1591-8. PubMed ID: 16801584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.
    Petak SM; Nankin HR; Spark RF; Swerdloff RS; Rodriguez-Rigau LJ;
    Endocr Pract; 2002; 8(6):440-56. PubMed ID: 15260010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism.
    Yamaguchi K; Ishikawa T; Chiba K; Fujisawa M
    Andrologia; 2011 Feb; 43(1):52-6. PubMed ID: 21219383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis in Klinefelter's syndrome.
    Ferlin A; Schipilliti M; Di Mambro A; Vinanzi C; Foresta C
    Mol Hum Reprod; 2010 Jun; 16(6):402-10. PubMed ID: 20348548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.
    Schubert M; Jockenhövel F
    J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and laboratoristic strategy in late onset hypogonadism.
    Lombardo F; Lupini C; Meola A; Pallotti F; Gandini L; Lenzi A
    Acta Biomed; 2010; 81 Suppl 1():85-8. PubMed ID: 20518196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.
    Guo CY; Jones TH; Eastell R
    J Clin Endocrinol Metab; 1997 Feb; 82(2):658-65. PubMed ID: 9024272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment topics: I. Pathophysiology, diagnosis and treatment; 13. Late onset hypogonadism syndrome].
    Horie S
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):914-21. PubMed ID: 23772507
    [No Abstract]   [Full Text] [Related]  

  • 30. Current topics in testosterone replacement of hypogonadal men.
    Nieschlag E
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone.
    Giustina A; Scalvini T; Tassi C; Desenzani P; Poiesi C; Wehrenberg WB; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1210-9. PubMed ID: 9100598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach.
    Rey RA; Grinspon RP; Gottlieb S; Pasqualini T; Knoblovits P; Aszpis S; Pacenza N; Stewart Usher J; Bergadá I; Campo SM
    Andrology; 2013 Jan; 1(1):3-16. PubMed ID: 23258624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Testosterone undecanoate for late -onset hypogonadism: an update].
    Fan XB; Huang YF
    Zhonghua Nan Ke Xue; 2010 Jan; 16(1):68-71. PubMed ID: 20180410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients.
    Amano T; Imao T; Takemae K; Iwamoto T; Nakanome M
    Aging Male; 2010 Dec; 13(4):242-6. PubMed ID: 20795793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone for 'late-onset hypogonadism' in men?
    Drug Ther Bull; 2010 Jun; 48(6):69-72. PubMed ID: 20530029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism.
    Laitinen EM; Hero M; Vaaralahti K; Tommiska J; Raivio T
    Int J Androl; 2012 Aug; 35(4):534-40. PubMed ID: 22248317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative bone SPECT in young males with delayed puberty and hypogonadism: implications for treatment of low bone mineral density.
    Lubushitzky R; Front D; Iosilevsky G; Bettman L; Frenkel A; Kolodny GM; Israel O
    J Nucl Med; 1998 Jan; 39(1):104-7. PubMed ID: 9443746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secondary osteoporosis. Late-onset hypogonadisim in the aging male.].
    Ogawa S
    Clin Calcium; 2018; 28(12):1641-1646. PubMed ID: 30487329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.